Comparison of quantitative cytomegalovirus real-time PCR in whole blood and pp65 antigenemia assay: clinical utility of CMV real-time PCR in hematopoietic stem cell transplant recipients

scientific article published on 29 July 2009

Comparison of quantitative cytomegalovirus real-time PCR in whole blood and pp65 antigenemia assay: clinical utility of CMV real-time PCR in hematopoietic stem cell transplant recipients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3346/JKMS.2009.24.4.571
P932PMC publication ID2719194
P698PubMed publication ID19654935
P5875ResearchGate publication ID26717139

P2093author name stringJong-Wook Lee
Sun Hee Park
Chun-Choo Kim
Dong-Gun Lee
Jin-Hong Yoo
Jung-Hyun Choi
Wan-Shik Shin
Woo-Sung Min
Yonggoo Kim
Su-Mi Choi
Kyungja Han
Jihyang Lim
P2860cites workCMV monitoring using blood cells and plasma: a comparison of apples with oranges?Q54558030
The effect of quantification standards used in real-time CMV PCR assays on guidelines for initiation of therapy in allogeneic stem cell transplant patients.Q54563527
Quantitative analysis of cytomegalovirus load using a real-time PCR assay.Q64953713
Evaluation of the CMV-vue antigenemia assay for rapid detection of cytomegalovirus in peripheral blood leukocytesQ72794001
Cytomegalovirus quantification in plasma by an automated real-time PCR assayQ79828069
Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic stem cell transplant recipientsQ80525527
Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomesQ31835044
Real-time automated PCR for early diagnosis and monitoring of cytomegalovirus infection after bone marrow transplantationQ33968089
Quantification of human cytomegalovirus DNA in bone marrow transplant recipients by real-time PCR.Q33974273
Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipientsQ34439235
Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasmaQ34991529
Automated extraction and quantification of human cytomegalovirus DNA in whole blood by real-time PCR assayQ35638781
Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.Q36597473
Quantitation of cytomegalovirus: methodologic aspects and clinical applications.Q39468915
Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipientsQ39626863
Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipientsQ39732759
Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemiaQ40186252
Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipientsQ40507092
Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detectionQ40762485
Analytic validation of a quantitative real-time PCR assay to measure CMV viral load in whole bloodQ43590471
The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV diseaseQ43940394
Monitoring cytomegalovirus infection by antigenemia assay and two distinct plasma real-time PCR methods after hematopoietic stem cell transplantationQ44214552
Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of preemptively treated children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemiaQ44618517
In vitro model for the study of the dissociation of increasing antigenemia and decreasing DNAemia and viremia during treatment of human cytomegalovirus infection with ganciclovir in transplant recipientsQ44669550
Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in KoreaQ45271053
Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load > or =10000 copies/ml: a safe and effective strategy for allogeneic stem cell transplant patientsQ46801387
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P433issue4
P921main subjectstem cell transplantationQ65592366
CytomegalovirusQ6946
whole bloodQ7997549
P304page(s)571-578
P577publication date2009-07-29
P1433published inJournal of Korean Medical ScienceQ24039955
P1476titleComparison of quantitative cytomegalovirus real-time PCR in whole blood and pp65 antigenemia assay: clinical utility of CMV real-time PCR in hematopoietic stem cell transplant recipients
P478volume24

Reverse relations

cites work (P2860)
Q44535281Circulating IL-17 levels during the peri-transplant period as a predictor for early leukemia relapse after myeloablative allogeneic stem cell transplantation
Q41041259Clinical Utility of Viral Load in the Management of Cytomegalovirus Infection in Solid Organ Transplant Patients in Kuwait
Q87765255Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning
Q41566881Comparison of quantitation of cytomegalovirus DNA by real-time PCR in whole blood with the cytomegalovirus antigenemia assay.
Q36288594Correlation and clinical utility of pp65 antigenemia and quantitative polymerase chain reaction assays for detection of cytomegalovirus in pediatric renal transplant patients
Q42275611Cytomegalovirus DNAemia detected with real-time polymerase chain reaction in hematopoietic stem cell transplant patients
Q43735414Cytomegalovirus infection in pediatric allogenic hematopoietic stem cell transplantation. A single center experience.
Q33889365Diagnosis of cytomegalovirus pneumonia by quantitative polymerase chain reaction using bronchial washing fluid from patients with hematologic malignancies
Q40655846Effects of Granulocyte and Monocyte Adsorptive Apheresis in Renal Transplantation Recipients With Concomitant Cytomegalovirus Infection.
Q102075443Efficacy of low dose antithymocyte globulin on overall survival, relapse rate, and infectious complications following allogeneic peripheral blood stem cell transplantation for leukemia in children
Q53132522Impact of cytomegalovirus gastrointestinal disease on the clinical outcomes in patients with gastrointestinal graft-versus-host disease in the era of preemptive therapy.
Q37086251Impact of cytomegalovirus reactivation on relapse and survival in patients with acute leukemia who received allogeneic hematopoietic stem cell transplantation in first remission
Q52728829Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea.
Q41092916Long-term clinical outcomes of hematopoietic cell transplantation for intermediate-to-poor-risk acute myeloid leukemia during first remission according to available donor types
Q41373726Monitoring human cytomegalovirus infection in pediatric hematopoietic stem cell transplant recipients: using an affordable in-house qPCR assay for management of HCMV infection under limited resources.
Q38694426Outcomes of allogeneic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria with or without aplastic anemia
Q42977950Preemptive therapy for cytomegalovirus based on real-time measurement of viral load in liver transplant recipients
Q37763611Public health and laboratory considerations regarding newborn screening for congenital cytomegalovirus
Q92741448Relationship of Circulating Cytomegalovirus Levels Obtained Through Antigenemia Testing and Quantitative PCR Differs Between Children and Adults
Q35226610SOCS1 and SOCS3 are expressed in mononuclear cells in human cytomegalovirus viremia after allogeneic hematopoietic stem cell transplantation
Q51753093Similar outcomes of peripheral blood stem cells vs. bone marrow for human leukocyte antigen-matched unrelated donor transplantation in adult patients with acute myeloid leukemia using risk-adapted graft-versus-host disease prophylaxis.
Q33591729Surveillance of active human cytomegalovirus infection in hematopoietic stem cell transplantation (HLA sibling identical donor): search for optimal cutoff value by real-time PCR.